Seattle

Be Biopharma Announces Oral Presentation on Precise Genome Engineering of Human B Cells to Express Diverse Therapeutic Proteins at American Society of Gene & Cell Therapy 26th Annual Meeting

Retrieved on: 
Thursday, May 18, 2023
Health, Clinical Trials, Research, Pharmaceutical, Science, Biotechnology, CRISPR, SMPD1, Factor IX, Gene, Acute lymphoblastic leukemia, ALL, Seattle, Engineering, Bone marrow, Cancer, ASM, Therapure BioPharma Inc, FIX, HDR, PST, AAV, Plasma cell, Plasma, Protein, Transgene, Spleen, Patient, Risk, Haemophilia, Flow cytometry, Annual general meeting, Cell, CCR5, Notifiable disease, Phenotype, Society, PCR, Disease, Vaccine, NPD

Be Biopharma, Inc. (“Be Bio”), a company pioneering the discovery and development of Engineered B Cell Medicines (BeCMs), will present preclinical research today showing the precise genome engineering of human B cells to express diverse therapeutic proteins using the company’s proprietary platform.

Key Points: 
  • Be Biopharma, Inc. (“Be Bio”), a company pioneering the discovery and development of Engineered B Cell Medicines (BeCMs), will present preclinical research today showing the precise genome engineering of human B cells to express diverse therapeutic proteins using the company’s proprietary platform.
  • The findings will be presented during an oral session at the American Society of Gene & Cell Therapy (ASGCT) 26th Annual Meeting at 2:15-2:30 p.m. PST with additional data in poster presentation 1453 on Friday, May 19th from 12:00-2:00 p.m. PST.
  • However, it has historically been challenging to genetically engineer B cells efficiently, precisely, and in a manner that could produce proteins at therapeutic levels over long durations.
  • These fundamental platform attributes overcome historical challenges for scalable and effective B cell engineering.

GeneDx Adds Buccal Swab as Non-Invasive Whole Genome Sequencing Sample Collection Option

Retrieved on: 
Thursday, May 4, 2023
DNA, University, Pediatrics, GeneDx, Seattle, Parent, Cell, Inherited patterned lentiginosis, Associate, Whole genome sequencing, Genetics, Patient, Animal testing at the University of Washington, WGS, National Association Medical Staff Services, Vaccine

Sequencing biological parent genomes alongside patient genomes – known as trio analysis - aids in disease diagnosis and greatly increases diagnostic yield rates.

Key Points: 
  • Sequencing biological parent genomes alongside patient genomes – known as trio analysis - aids in disease diagnosis and greatly increases diagnostic yield rates.
  • "We are continuously looking for ways to broaden adoption of genome sequencing and facilitate convenient access to families to aid in disease diagnosis,” said Paul Kruszka, M.D., Chief Medical Officer at GeneDx.
  • Adding buccal swab as an additional sample collection method for our GenomeSeqDx and GenomeXpress whole genome sequencing tests can make it easier for providers to collect parent samples for trio testing.”
    Buccal swab is a convenient, non-invasive method to collect DNA from cells found inside a person’s cheek.
  • Buccal swab DNA collection for parents will streamline the process and prevent delays in testing and enable us to do a more thorough whole genome analysis.”

Be Biopharma Announces First Scientific Disclosures and New Preclinical Data Supporting the Advancement of B Cell Medicines at the American Society of Gene & Cell Therapy 26th Annual Meeting

Retrieved on: 
Tuesday, May 2, 2023
Science, Stem Cells, Biotechnology, Research, Pharmaceutical, Oncology, General Health, Health, Gene, Senior, Engineering, Seattle, National Heart, Lung, and Blood Institute, Therapure BioPharma Inc, Lung, National Institutes of Health, Bangladesh Technical Education Board, B cell, Annual general meeting, Cell, Society, Vaccine, Modularity

In a separate oral presentation, the precise engineering of B cells using Be Bio’s proprietary engineering platform will be featured.

Key Points: 
  • In a separate oral presentation, the precise engineering of B cells using Be Bio’s proprietary engineering platform will be featured.
  • Additionally, a poster presentation will show the stable expression and continuous secretion of therapeutic proteins in vitro and in vivo.
  • Finally, Be Bio’s scientific co-founders and collaborators from the Seattle Children’s Research Institute will present findings in which engineered B cells produced Bi-specific T cell engagers that mediated T cell activation and showed in vivo anti-tumor efficacy in a patient-derived xenograft model.
  • “Data from our preclinical research programs support the ability of Be Bio’s platform to unlock the power of B cells as the basis for a prolific and versatile product engine,” said Dr. Rick Morgan, Chief Scientific Officer, Be Bio.

Kroll Strengthens Industry-Leading Security Program With the Appointment of David Dunn as Chief Information Security Officer

Retrieved on: 
Monday, March 6, 2023
Professional Services, Insurance, Finance, Darknet, CISO, The Secret Service, Law enforcement, Research, Growth, Intelligence, Darknet Diaries, Seattle, Seattle Police Department, Risk, Dunn, Private sector, Secret Service, Cryptocurrency

Kroll , the leading independent provider of global risk and financial advisory solutions, announced today the appointment of David Dunn as Chief Information Security Officer (CISO).

Key Points: 
  • Kroll , the leading independent provider of global risk and financial advisory solutions, announced today the appointment of David Dunn as Chief Information Security Officer (CISO).
  • Previously, Dunn served as Deputy Chief Information Security Officer since he joined Kroll in 2016, where he managed the global security operations center, incident response, security engineering, threat intelligence, security architecture and vulnerability management groups.
  • In his new role, Dunn will continue to strengthen the firm’s security program to address the evolving and complex threat landscape.
  • His new remit also includes applying Kroll’s leading security best practices to ensure that the firm’s information security program continues to meet evolving risk and compliance requirements as well as client needs and expectations.

BERMUDA TOURISM AUTHORITY ANNOUNCES STAR-STUDDED LINEUP FOR THE INAUGURAL BERMUDA CELEBRITY GOLF INVITATIONAL, PRESENTED BY CHUBB

Retrieved on: 
Thursday, March 2, 2023
Love, Philadelphia Eagles, Pittsburgh Steelers, Port Royal Golf Course, Metta Sandiford-Artest, Tourism, Workplace, Los Angeles Lakers, NFL, Buffalo Bills, Business, Sport, Travel, Premier Boxing Champions, Tampa Bay Buccaneers, MLB, New York Giants, BTA, Boxing, International, R, Golf, Athlete, Seattle SuperSonics, Naming, Seattle, Entertainment

Hamilton, Bermuda, March 02, 2023 (GLOBE NEWSWIRE) -- Bermuda Tourism Authority (BTA) announces the inaugural Bermuda Celebrity Golf Invitational from April 26th to May 1st at Port Royal Golf Course, the first event of its kind ever to take place on the island.

Key Points: 
  • Hamilton, Bermuda, March 02, 2023 (GLOBE NEWSWIRE) -- Bermuda Tourism Authority (BTA) announces the inaugural Bermuda Celebrity Golf Invitational from April 26th to May 1st at Port Royal Golf Course, the first event of its kind ever to take place on the island.
  • "We look forward to our invited celebrity guests showcasing their love of golf while simultaneously indulging in our island's enchanting appeal," said Tracy Berkeley, Bermuda Tourism Authority Interim CEO.
  • The Bermuda Celebrity Golf Invitational kicks off a jam-packed week of golfing activities on the island, including Black Golfers Week, kicking off Thursday, April 27th.
  • For a full schedule, available packages, and more information on Black Golfers Week, please visit GoToBermuda.com.

Head to HBO Max for All Things Elvis March 1st – 14th

Retrieved on: 
Tuesday, February 28, 2023
Film & Motion Pictures, TV and Radio, Music, Online, General Entertainment, Technology, Carriers and Services, Entertainment, HBO, Warner Bros., Baz, Seattle, HBO Max, Elvis Presley, Multimedia, Grand Prix, Warner, Film industry, Tupelo

Starting Wednesday, March 1st, Elvis aficionados can find a newly collected array of exciting Elvis Presley-based entertainment streaming on HBO Max through March 14th—The Elvis Presley Collection.

Key Points: 
  • Starting Wednesday, March 1st, Elvis aficionados can find a newly collected array of exciting Elvis Presley-based entertainment streaming on HBO Max through March 14th—The Elvis Presley Collection.
  • That’s why it’s really exciting to see HBO Max embracing all that Elvis Presley had to offer, and in turn offering that to its subscribers.
  • “Elvis Presley: The Searcher” – This comprehensive two-part 2018 HBO Documentary Film from award-winning director Thom Zimny explores Elvis Presley’s lifelong creative journey, from childhood through his 1976 “Jungle Room” recording sessions.
  • “Elvis: That’s the Way It Is” – The King of Rock ‘n’ Roll prepares himself for one of his biggest Vegas shows ever.

Baseball Beyond Borders and Converge Media Release Revolutionary 'Reconciliation Tour' Documentary

Retrieved on: 
Monday, February 27, 2023
Converge, Equal, Alaska Airlines, Heart, Left–right political spectrum, Negro National League, Seattle Mariners Hall of Fame, BBB, Hope, Negro National League (1920–1931), Jackson State University, Baseball, Seattle, Nightclub, Tourism

SEATTLE, Feb. 27, 2023 /PRNewswire/ -- Baseball Beyond Borders (BBB), Seattle's sports-based community development organization, released its first documentary film, "Reconciliation Tour."

Key Points: 
  • SEATTLE, Feb. 27, 2023 /PRNewswire/ -- Baseball Beyond Borders (BBB), Seattle's sports-based community development organization, released its first documentary film, "Reconciliation Tour."
  • The documentary takes a powerful journey through the heart of the south, including youth baseball, civil rights, and reconciliation.
  • Kids are introduced to baseball for the first time as the organization keeps its promise to elevate and empower through the sport.
  • Black baseball traditions are honored, and the participants understand the contributions brought to this game, including establishing the Negro National League.

BDA Appoints Rob Martin for Newly Created Chief Experience Officer Role

Retrieved on: 
Monday, February 27, 2023
Marketing, Johnson & Johnson, Trust, The Home Depot, Merchandising, Heart, NBC, Seattle, Major League Baseball, Seattle SuperSonics, Growth, BDA, NBA, CXO, Paramount, Mercedes-Benz

WOODINVILLE, Wash., Feb. 27, 2023 /PRNewswire/ -- Bensussen Deutsch & Associates, LLC (BDA), the nation's premier Merchandise Agency™ for iconic brands including Major League Baseball, Johnson & Johnson, The Home Depot, NBC, and Mercedes Benz, today announced the appointment of Rob Martin as Chief Experience Officer (CXO). With BDA's rapid growth and expansion of its client roster, the creation of the CXO role will ensure a continued focus on delivering an outstanding client experience. With nearly 15 years in leadership roles at BDA, Rob has been at the forefront of growing the agency through global expansion, new client partnerships, acquisitions, corporate marketing, and managing massive technology infrastructure initiatives.

Key Points: 
  • With BDA's rapid growth and expansion of its client roster, the creation of the CXO role will ensure a continued focus on delivering an outstanding client experience.
  • Prior to his CXO appointment, Rob served as Chief Operating Officer, where he ran BDA's global operations, fulfillment centers, supplier partners, and sales support.
  • Before that, Rob held the title of Chief Marketing Officer leading all strategic marketing and communication initiatives.
  • This offers me a unique perspective as I take on the role of Chief Experience Officer," said Rob Martin.

Miller Mendel Welcomes Seattle Police Department to the eSOPH Background Investigation Network

Retrieved on: 
Monday, January 16, 2023
Seattle, Vancouver Police Department, Social media, Seattle Police Department, Personal History, Private investigator

SEATTLE, Jan. 16, 2023 (GLOBE NEWSWIRE) -- Miller Mendel, Inc. welcomes the Seattle Police Department to its eSOPH background Investigation software system.

Key Points: 
  • SEATTLE, Jan. 16, 2023 (GLOBE NEWSWIRE) -- Miller Mendel, Inc. welcomes the Seattle Police Department to its eSOPH background Investigation software system.
  • The Seattle Police Department joins over 165 public safety agencies across the nation that have transitioned pre-employment background investigations to the eSOPH system.
  • The Seattle Police Department expects to process at least 1000 applicants per year using eSOPH.
  • By transitioning to eSOPH, the Seattle Police Department joins several other Washington agencies using the eSOPH system, to include the King County Sheriff’s Office, Pierce County Sheriff’s Department, Clark County Sheriff’s Office, Vancouver Police Department, and several others.

Antibody Drug Conjugate Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2022 to 2030 - ResearchAndMarkets.com

Retrieved on: 
Thursday, January 5, 2023
Health, Pharmaceutical, Antigen, Cytotoxicity, Isotope, Research, Seattle, Antibody-drug conjugate, Overalls, Cytokine, Therapy, Roche, Control, Seagen, Fine chemical, Trastuzumab emtansine

The "Antibody Drug Conjugate Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2022 to 2030" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Antibody Drug Conjugate Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2022 to 2030" report has been added to ResearchAndMarkets.com's offering.
  • The report offers strategic insights into the overall Antibody Drug Conjugate market along with the market size and estimates for the duration 2022 to 2030.
  • In base year 2021, North America accounted for the largest market in the antibody drug conjugate market due to the presence of major pharmaceutical companies working on the development of antibody drug conjugate drugs.
  • Fast-track approvals of breakthrough drugs in Asia-Pacific would further drive the antibody drug conjugate market during the forecast period.